Michael S. Rafii
Affiliations: | 2008-2016 | Neuroscience | University of California, San Diego, La Jolla, CA |
2016- | Neurology | University of Southern California Keck School of Medicine |
Area:
Neurodegenerative DiseasesGoogle:
"Michael Rafii"Mean distance: 15.77 (cluster 11) | S | N | B | C | P |
Parents
Sign in to add mentorCarl W. Cotman | research assistant | UC Irvine | ||
Justin R. Fallon | grad student | 1997-2002 | Brown | |
(Roles for the proteoglycan biglycan in muscular dystrophy and neuromuscular junction formation.) | ||||
Leon J. Thal | post-doc | 2006-2008 | UCSD | |
Paul S. Aisen | research scientist | 2007-2007 |
Collaborators
Sign in to add collaboratorJames B. Brewer | collaborator | Johns Hopkins | |
Anders M. Dale | collaborator | UCSD | |
Robert A Rissman | collaborator |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Russell JK, Conley AC, Boyd BD, et al. (2025) Brain cholinergic terminal density utilizing [F]-fluoroethoxybenzovesamicol PET in adults with Down's syndrome: Relationship to amyloid PET and cognitive performance. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 21: e70134 |
Jimenez-Maggiora GA, Donohue MC, Rafii MS, et al. (2025) Artificial intelligence-enabled safety monitoring in Alzheimer's disease clinical trials. The Journal of Prevention of Alzheimer's Disease. 12: 100002 |
Sukreet S, Goodwill V, Ngolab J, et al. (2025) Basic Science and Pathogenesis. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. e092874 |
Leal CBQS, Zimmer CGM, Sinatti VVC, et al. (2024) Effects of the therapeutic correction of U1 snRNP complex on Alzheimer's disease. Scientific Reports. 14: 30085 |
Rafii MS. (2024) The amyloid clock: mapping Alzheimer's disease in Down syndrome. The Lancet. Neurology. 23: 1173-1174 |
Boerwinkle AH, Wisch JK, Handen BL, et al. (2024) The mediating role of plasma glial fibrillary acidic protein in amyloid and tau pathology in Down's syndrome. Alzheimer's & Dementia : the Journal of the Alzheimer's Association |
Sukreet S, Goodwill VS, Ngolab J, et al. (2024) Clinical and neuropathological analysis of Down syndrome over 7 decades of life. Journal of Neuropathology and Experimental Neurology |
Aisen PS, Donohue MC, Raman R, et al. (2024) The Alzheimer's Disease Neuroimaging Initiative Clinical Core. Alzheimer's & Dementia : the Journal of the Alzheimer's Association |
Jack CR, Andrews SJ, Beach TG, et al. (2024) Revised criteria for the diagnosis and staging of Alzheimer's disease. Nature Medicine |
Krasny S, Yan C, Hartley SL, et al. (2024) Assessing amyloid PET positivity and cognitive function in Down syndrome to guide clinical trials targeting amyloid. Alzheimer's & Dementia : the Journal of the Alzheimer's Association |